HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 204 filers reported holding HERON THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 2.25 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $8,117,000 | -68.1% | 691,400 | -36.1% | 1.39% | -57.3% |
| Q4 2019 | $25,407,000 | +25.9% | 1,081,159 | -0.9% | 3.25% | +6.5% |
| Q3 2019 | $20,186,000 | -1.2% | 1,091,110 | -0.7% | 3.05% | +7.6% |
| Q2 2019 | $20,425,000 | -24.9% | 1,098,723 | -1.3% | 2.84% | -19.8% |
| Q1 2019 | $27,201,000 | +27.1% | 1,112,966 | +34.9% | 3.54% | +3.6% |
| Q4 2018 | $21,407,000 | -18.8% | 825,269 | -0.9% | 3.41% | -19.8% |
| Q3 2018 | $26,364,000 | -18.9% | 833,001 | -0.4% | 4.25% | -15.9% |
| Q2 2018 | $32,507,000 | +148.9% | 836,737 | +76.8% | 5.06% | +76.5% |
| Q1 2018 | $13,062,000 | +74.4% | 473,275 | +14.4% | 2.87% | +39.7% |
| Q4 2017 | $7,488,000 | +17.8% | 413,721 | +5.1% | 2.05% | +2.0% |
| Q3 2017 | $6,355,000 | +24.9% | 393,505 | +7.1% | 2.01% | +17.9% |
| Q2 2017 | $5,088,000 | -6.7% | 367,390 | +1.0% | 1.71% | -18.1% |
| Q1 2017 | $5,455,000 | – | 363,689 | – | 2.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 8,648,252 | $238,692,000 | 35.08% |
| Broadfin Capital, LLC | 1,581,416 | $43,647,000 | 6.80% |
| Tavio Capital LLC | 351,729 | $9,708,000 | 4.58% |
| Mesirow Financial Investment Management, Inc. | 33,389 | $922,000 | 3.88% |
| Rubric Capital Management LP | 1,510,008 | $41,676,000 | 3.88% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,666,229 | $45,988,000 | 3.63% |
| First Light Asset Management, LLC | 473,275 | $13,062,000 | 2.87% |
| Asymmetry Capital Management, L.P. | 77,346 | $2,135,000 | 2.67% |
| Copernicus Capital Management, LLC | 108,000 | $2,981,000 | 2.38% |
| BRIDGER MANAGEMENT, LLC | 1,277,560 | $35,261,000 | 2.14% |